Oxford Bioscience Partners

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance

Business Model:

Revenue: $15.3M

Employees: 2-10

Rankings

Detailed Oxford Bioscience Partners Information

Geographic Data

Oxford Bioscience Partners headquarters map

Address: 12 Giles Place

City: Mansfield

State: MA

Zip: 02048

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.

Contact Phone:
+16173577474

Contact Email:

Announced Date Company Transaction Money Raised
6/2006 BioProcessors Series C 18M
3/2009 Claros Diagnostics Series B 0
11/2003 Asterand Series C 3M
11/2006 Solstice Neurosciences Series B 85M
1/2007 Hydrocision Series G 12.7M
10/2007 Xencor Series E 15M
3/2000 Variagenics Funding Round 19M
7/2003 Alantos Pharmaceuticals Series B 27.7M
3/2008 BrainCells Series B 30M
1/2003 Percutaneous Valve Technologies (PVT) Series B 14M
9/2004 Courtagen Life Sciences Venture Round 6.6M
1/2007 CircuLite Series B 10.2M
1/2017 Yolia Health Series A 3M
3/2009 Seahorse Bioscience Series D 6M
5/2008 ZettaCore Series C 15M
3/2003 Hypnion Series B 47.5M
11/2007 Courtagen Life Sciences Venture Round 9.5M
5/2004 Mitralign Series A 0
7/1999 Exelixis Seed Round 4M
4/2007 Coherex Medical Series A 8.5M
6/2005 Mitralign Venture Round 6.7M
12/2004 CircuLite Series A 7M
2/2005 Acadia Pharmaceuticals Inc. Post-IPO Equity 10M
7/2005 BrainCells Series A 0
3/2007 Adastra Pharmaceuticals Series A 40M
5/2004 Ensemble Therapeutics Series A 15M
7/2003 Cyberkinetics Series A 9.3M
2/2006 Acadia Pharmaceuticals Inc. Post-IPO Equity 20M
1/2012 Glori Energy Series C 0
2/2002 BioProcessors Series A 6M
12/2006 Hydrocision Series G 12.7M
7/2008 Dicerna Pharmaceuticals Series A 8.4M
2/2006 Courtagen Life Sciences Venture Round 7.6M
2/2011 CardioFocus Series C 0
5/2014 CardioFocus Debt Financing 0
3/2009 Pathway Medical Technologies Series D 42.5M
3/2005 Alantos Pharmaceuticals Series B 0
4/2007 CircuLite Series B 5M
1/2010 CircuLite Series C 32.5M
12/2003 Xanthus Pharmaceuticals Series B 0
1/2004 Accelerated Technologies Series B 32M
6/2006 Mitralign Series B 13M
12/2008 Luca Technologies Series C 75.9M
3/2007 Affinium Pharmaceuticals Series A 18M
11/2005 FlowMedica Series D 0
5/2007 Intechra Holdings Series C 0
3/2010 Seahorse Bioscience Series D 5M
10/2000 Hypnion Series A 10.4M
6/2009 VaxInnate Series D 30M
11/2006 Elixir Pharmaceuticals Series C 0
2/2005 Cambrios Technologies Series B 12M
8/2004 Cambrios Technologies Series A 1.8M
4/2007 Cambrios Technologies Series C 18.5M
11/2009 Cambrios Technologies Series D 14.5M
10/2003 Elixir Pharmaceuticals Series B 40.5M
7/2004 Trubion Pharmaceuticals Series B 32M
5/2012 Mitralign Series D 0
5/2004 Ensemble Discovery Series A 15M
11/2007 Ensemble Discovery Series B 15M
1/2000 CardioFocus Series B 0
11/2006 Pathway Medical Technologies Series B 25M
4/2003 Sirna Therapeutics Venture Round 48M
7/2002 Scion Pharmaceuticals Series B 0
6/2006 Melinta Therapeutics Series C 0
7/2004 Intrapace Series C 0
2/1998 Agromed Venture Round 8.2M
3/2003 Acadia Pharmaceuticals Inc. Series F 25M
9/2004 Solexa Series B 0
12/2007 Mitralign Series C 0
11/2008 Molecular Biometrics Series A 12M
6/2002 Zone Labs Series C 0
5/2002 ImpactRx Series C -
1/2010 ImpactRx Series E 0
8/2007 BioProcessors Series C 10M
8/2004 Enanta Pharmaceuticals Venture Round 20M
1/2010 Molecular Biometrics Series B 12.5M
1/2004 ZettaCore Series B 17.5M
10/2009 Coherex Medical Series B 16.5M
5/2001 Zone Labs Series B 0
9/2010 SuperDimension Debt 15M
7/2003 Cohesive Technologies Series B 9.5M
1/2001 Percutaneous Valve Technologies (PVT) Series A 5.5M
10/2007 Luca Technologies Series B 20M
4/2007 Radius Health Series B 57.5M
1/2002 Melinta Therapeutics Series A 22M
1/1999 Message Pharmaceuticals Venture Round 6.3M
8/2001 CardioFocus Series C 0
4/2010 Adastra Pharmaceuticals Venture Round 0
3/2003 Catalyst Bioscience Venture Round 60M
7/2005 Solstice Neurosciences Venture Round 8M
1/2003 SuperDimension Venture Round 13M
1/2004 Enanta Pharmaceuticals Venture Round 0
9/2013 Affinium Pharmaceuticals Debt Financing 0
5/2004 PowderMed Series A 35.8M
10/2002 MicroMed Technology Series D 23M
11/2001 Scion Pharmaceuticals Series A 4M
1/2007 Claros Diagnostics Series A 0
4/2007 Nfocus Neuromedical Series B 20.3M
7/2002 Enanta Pharmaceuticals Series E 18.3M
1/2008 Hydrocision Series H 4.8M
7/2003 BioProcessors Series B 13M
11/2002 Dynogen Pharmaceuticals Series A 13.3M
7/2013 Dicerna Pharmaceuticals Series C 0
3/2005 Pathway Medical Technologies Series A 15M
4/2001 NotifyMD Venture Round 6.1M
9/2021 Paperspace Series F 0
1/2001 CytoLogix Series B 0
1/2009 Melinta Therapeutics Series D 0
10/2003 Critical Therapeutics,Inc. Series B 56M
3/2004 VaxInnate Series B 23.1M
10/2006 VaxInnate Series C 40M
1/2008 Select Laboratory Partners Series D 16M
10/2004 FlowMedica Series C 0
1/2003 Impella Cardiosystems Venture Round 40M
12/2005 Santhera Pharmaceuticals Series B 0
11/2008 Radius Health Series C 15M
5/2009 Elixir Pharmaceuticals Series D 12M
12/2005 Hypnion Series B 0
9/2010 SuperDimension Equity 9.8M
10/2003 AVEO Oncology Series B 42.7M
7/2000 Enanta Pharmaceuticals Series B 20M
6/2001 Hydrocision Series B 2M
9/2021 Paperspace Series F 0
1/2017 Yolia Health Series A 0
5/2014 CardioFocus Debt Financing 0
9/2013 Affinium Pharmaceuticals Debt Financing 0
7/2013 Dicerna Pharmaceuticals Series C 0
5/2012 Mitralign Series D 0
1/2012 Glori Energy Series C 0
2/2011 CardioFocus Series C 0
9/2010 SuperDimension Venture Round 0
9/2010 SuperDimension Debt Financing 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research